Marisa N Barber, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 860 Oak Park Blvd, Ste 101, Arroyo Grande, CA 93420 Phone: 805-481-3685 Fax: 805-481-5245 |
Mrs. Hannah Scobel Pisklov, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 850 Fair Oaks Ave Ste 100, Arroyo Grande, CA 93420 Phone: 805-473-0700 Fax: 805-473-5931 |
Jeannin Counts, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 310 S Halcyon Rd Ste 106, Arroyo Grande, CA 93420 Phone: 805-568-7800 |
Eliza Hughes, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 860 Oak Park Blvd Ste 101, Arroyo Grande, CA 93420 Phone: 805-481-3685 |
Megan Renee Worth, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 310 S Halcyon Rd Ste 105, Arroyo Grande, CA 93420 Phone: 805-782-8844 Fax: 805-782-8859 |
Mr. Jason Aquino Buranday, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 860 Oak Park Blvd, Suite 101, Arroyo Grande, CA 93420 Phone: 805-481-3685 Fax: 805-481-5245 |
Mrs. Jessica C Joslyn, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 180 Le Point St, A & B, Arroyo Grande, CA 93420 Phone: 805-481-3442 |
Daniel Perry, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 880 Oak Park Blvd Ste 201, Arroyo Grande, CA 93420 Phone: 805-473-8346 |
Karilyn Suzanne Haut, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 310 S Halcyon Rd Ste 106, Arroyo Grande, CA 93420 Phone: 805-568-7800 |
News Archive
As a result of health law changes to provide seniors with "doughnut hole" relief, Medicare recipients saved a combined $260 million on medicines as of the end of last month.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
A novel - and rapid - anti-cancer drug development strategy has resulted in a new drug that stops kidney and pancreatic tumors from growing in mice. Researchers at the Moores Cancer Center at the University of California, San Diego, have found a drug that binds to a molecular "switch" found in cancer cells and cancer-associated blood vessels to keep it in the "off" position.
The Jamaican Ministry of Health and Environment has secured 40% of the funding needed to implement a $200 million, five-year strategy to fight the spread of HIV/AIDS in the country, Kevin Harvey - treatment, care and support coordinator at the health ministry - said recently, the Jamaica Observer reports.
› Verified 3 days ago